Oxford Asset Management’s GSK GSK Stock Holding History

Oxford Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-54,176	Closed	-$2.89M	–	1869
2019 Q3	$2.89M	Buy	54,176 +44,083	+437%	+$2.27M	0.07%	349
2019 Q2	$505K	Sell	10,093 -86,510	-90%	-$4.34M	0.01%	1272
2019 Q1	$5.05M	Sell	96,603 -16,579	-15%	-$828K	0.11%	209
2018 Q4	$5.41M	Buy	+113,182	New	+$5.57M	0.14%	168
2018 Q1	–	Sell	-185,162	Closed	-$8.22M	–	1722
2017 Q4	$8.22M	Buy	185,162 +66,527	+56%	+$3.07M	0.18%	113
2017 Q3	$6.02M	Sell	118,635 -11,767	-9%	-$597K	0.12%	181
2017 Q2	$7.03M	Buy	130,402 +82,472	+172%	+$4.4M	0.14%	149
2017 Q1	$2.53M	Buy	47,930 +39,828	+492%	+$2.02M	0.06%	356
2016 Q4	$390K	Buy	+8,102	New	+$400K	0.01%	628
2014 Q3	–	Sell	-86,727	Closed	-$5.82M	–	700
2014 Q2	$5.82M	Buy	+86,727	New	+$5.87M	0.19%	154

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Oxford Asset Management's GSK Position: Q4 2019 in Review

Oxford Asset Management sold out of GSK (GSK) in Q4 2019, closing a stake of 54,176 shares — an estimated $2.89M sold.

Oxford Asset Management first reported a position in GSK in Q2 2014 and held it in 10 quarters. The position peaked at $8.22M in Q4 2017. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

Oxford Asset Management reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 54,176 GSK shares in Q4 2019, an estimated $2.89M.
Oxford Asset Management first reported a position in GSK in Q2 2014 and held it in 10 quarters.
Oxford Asset Management's GSK position peaked at $8.22M in Q4 2017.
894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.